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Clinical characteristicsThe aim of this study was to simultaneously examine a wide range of risk factors and clinical characteristics in
their predictive value for the 1-year severity of depressive symptoms. Data from 789 participants in the
Netherlands Study of Depression and Anxiety (NESDA), a large psychiatric cohort study, with a major
depressive disorder (MDD) at baseline were used. Depression severity at 1-year follow-up was studied using
linear and multinomial logistic regression models. Results of the analyses showed that high neuroticism, no
partner and older age were found predictive of a poorer outcome independent of baseline clinical
characteristics. Further, comorbid anxiety disorder, ﬁrst episode, having a moderate subtype (vs.
melancholic), and higher baseline depression severity predicted poorer outcome. To conclude, both risk
factors and clinical characteristics independently predicted 1-year severity of depressive symptoms. The
ﬁndings indicate that the prediction of prognosis and identiﬁcation of persons at risk of a poor outcome
should not only be based on clinical characteristics, but on risk factors as well., VU University Medical Center
The Netherlands.
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Whereas in the literature several etiologic and developmental
models for major depressive disorder (MDD) have been proposed
(Teasdale, 1988; Kendler et al., 2000, 2006; Beck, 2008; Sjoholm et al.,
2009), the literature on prognostic models for MDD is relatively
scarce. It has been proposed that etiologic factors that increase the risk
of developing depression, like high neuroticism, may also play a role
in the prognosis of the disorder, for instance, in the cognitive
vulnerability theory and in the differential activation hypothesis
(Teasdale, 1988). Several studies indeed found that neuroticism
determined an unfavorable course (Enns and Cox, 1997; Spijker et al.,
2001; Mulder, 2002; Rhebergen et al., 2008). Risk factors other than
personality have also been associated with depression outcome. For
instance, childhood trauma and recent stressful life events have been
associated with a more chronic depression trajectory (Kessler, 1997;
Wiersma et al., 2009). Other factors such as a family history of MDD or
absence of a partner have been found to predict poorer course,
although not consistently (Keller et al., 1984; Bagby et al., 2002;Trivedi et al., 2006; Husain et al., 2009). Further, the presence of
comorbid somatic diseases has been associated with less favorable
depression outcomes (Bagby et al., 2002; Esposito and Goodnick,
2003; Spijker et al., 2004; Trivedi et al., 2006), while factors like
gender, age, race and socio-economic status have been inconsistently
associated with depression course (Keller et al., 1984; Simpson et al.,
1997; Spijker et al., 2001; Bagby et al., 2002; Esposito and Goodnick,
2003; Hollon et al., 2006; Trivedi et al., 2006; Kaptein et al., 2007).
Although these risk factors have thus been shown to possibly affect
the course of depression, no previous study of persons with a current
depression has thoroughly examined whether risk factors are
important course predictors independent of psychiatric indicators at
baseline, or whether their predictive value is completely explained by
differences in baseline clinical characteristics. By studying risk factors
and clinical characteristics simultaneously, better knowledge will be
obtained about the unique contribution of various risk and clinical
indicators to the course and prognosis of depression. This information
may aid clinicians in more efﬁcient identiﬁcation of those at high risk
of a poor course, can be helpful in choosing the best suited treatment
strategy, and makes that patients could be provided with better
information about their prognosis.
The aim of the present study in a large cohort of 789 adults with
MDD was to simultaneously examine a wide range of risk factors as
well as clinical characteristics in their predictive value for the one-
year severity of depressive symptoms.We expected that effects of risk
factors would largely be mediated by clinical characteristics.
227F. Lamers et al. / Psychiatry Research 190 (2011) 226–2312. Methods
2.1. Study sample
Data were derived from the Netherlands Study of Depression and Anxiety (NESDA), a
prospective, longitudinal cohort study (N=2981) aimed at examining the long-term
course of depressive and anxiety disorders. The cohort consists of persons with current or
remitted depressive and/or anxiety disorders (6-month current, n=1701; remitted
n=628) and healthy controls (n=652). Participants, aged 18–65 years, were recruited
from the community (n=564, 19%), primary care (n=1610, 54%) and specializedmental
health care (n=807, 27%). In primary care, all persons consulting their GP in the last
4 months irrespective of reason for consultation were screened for the presence of
depression and anxiety symptoms (Kessler-10 with additional questions regarding
symptomsof anxiety), andwhenhavingapositive score, invited for a diagnostic interview,
after which persons with a conﬁrmed diagnosis were invited to participate. In specialized
mental health care settings, all newly enrolled patients were invited to participate in the
NESDA. All participants recruited from the community (n=564) previously participated
in longitudinal studies (NEMESIS (Bijl et al., 1998) ARIADNE (Landman-Peeters et al.,
2005; Penninx et al., 2008)). Exclusion criteria used in the NESDA were (1) a primary
clinical diagnosis of a psychiatric disordernot under study in theNESDAand thatwould be
expected to affect course trajectory: psychotic disorder, obsessive compulsive disorder,
bipolar disorder, or severe addiction disorder, and (2) not being ﬂuent in Dutch. More
details about the design and recruitment of the NESDA study are reported elsewhere
(Penninx et al., 2008). Approval of the study protocol was granted by the Ethical Review
Board of the VU University Medical Center and all participants gave written informed
consent. The baseline assessment included a 4-hour interview in which information on a
wide range of domains was collected, like psychopathology, demographic characteristics,
physical and psychosocial functioning and further included a medical assessment,
computer tasks and two self-administered questionnaires. At 1-year follow up,
participants ﬁlled out a self-administered questionnaire to determine the course of
anxiety and depressive symptoms.
For the present study, all persons with a current (1 month recency) DSM-IV major
depressive disorder (MDD) (n=802) at baseline were selected. The presence of MDD
was assessed using the Composite International Diagnostic Interview (CIDI), WHO
version 2.1 (World Health Organization, 1997). The CIDI is a reliable and valid
instrument to assess DSM-IV depressive diagnoses(Wittchen, 1994), and was assessed
by specially trained research staff. Of the selected sample (n=802), 13 persons (1.6%)
had missing data on the depressive symptom assessment both at baseline and at 1-year
follow-up and were subsequently excluded for the present analyses. Of the remaining
respondents (n=789), 194 (25%) did not provide data for the dependent variable, the
Inventory of Depressive Symptomatology (IDS), at the 1-year follow-up. Those with
missing data were younger (39.3 vs. 42.6 yrs, p=0.001), less educated (10.4 vs.
11.6 yrs, pb0.001), more often of non-North-European descent (12.1% vs. 5.6%,
p=0.002) and had lower rates of recurrent depression (44.7% vs. 52.9%, pb0.05)
than those who had nomissing data. No differences between groups were found for any
of the other indicators of MDD (e.g. subtype of MDD, baseline IDS score, duration of
symptoms, age at onset), or for age, gender and other demographics. Because case
deletion may introduce bias, it is preferable to maintain information from persons with
missing data by using techniques that impute data for missingness based on all
available data and account for missing-data uncertainty (Schafer and Olsen, 1998;
Sinharay et al., 2001). Therefore, the sample which we report on in the present study
consists of the 789 persons with MDD at baseline.
2.2. Severity of depressive symptoms
The Inventory of Depressive Symptomatology self-report version (Rush et al., 1996)
was used to assess symptom severity at baseline and at 1-year follow-up. The
questionnaire consists of 28 items on depressive symptoms rated on a 4-point scale. The
summed score ranges from 0 to 84, with higher scores indicating a higher depression
severity. The validity and reliability of the IDS have been shown to be satisfactory (Rush et
al., 1996). Mean number of days between the two assessments was 394 days (S.D. 73).
Along with the IDS score at 1-year follow-up, a second outcome measure was
constructed, representing extreme groups that are of speciﬁc interest from a clinical point
of view, namely remitters and persons with severe symptom severity after 1 year. In this
categorical variable, one category consisted of persons with an IDS scoreb14 at 1-year
follow-up, representing a group of remitted persons (Rush et al., 2003). A second category
consisted of persons who had an IDS scoreN38 at follow-up, representing a group with
severe symptoms and thus poor outcome(Rushet al., 2003). The third category comprised
all persons scoring mild to moderate depressive symptoms at follow-up, which served as
the reference group.
2.3. Determinants of depressive symptoms at 1-year follow-up
2.3.1. Risk factors
Family history was assessed using the Family Informant Schedule and Criteria
(Mannuzza et al., 1985). Respondents were asked whether family members ever had a
depression, and those reporting ﬁrst-degree family members (parents or siblings) with
depression were considered to have a positive family history. Childhood trauma was
deﬁned using the structured inventory from the NEMESIS study that constructs an index
(range 0–4) incorporating the occurrence and frequency of four types of abuse before age
16 (emotional neglect, psychological abuse, physical abuse and sexual abuse) (Wiersmaetal., 2009). A count of negative life events in the past yearwas constructed based on a list of
12negative life events (Brughaet al., 1985).Neuroticismwas assessedusing theNEO-Five-
Factor Inventory (Costa and McCrae, 1995). Further, during the interview, respondents
were asked about the presence of 21 somatic chronic diseases. A count of these diseases
was made, representing the somatic health status of respondents. Years of education,
partner status (yes/no), gender, age and ethnic background (North-European descent –
yes/no) were assessed in the baseline interview.
2.3.2. Baseline clinical characteristics
Duration of depressive symptoms at baseline (or chronicity) was assessed by the life
chart interview which used a calendar method to determine life events during the past
4 years to refreshmemory, and thenpresenceof depressive symptomsduring thepast 4 to
5 yearswas assessed (Lyketsoset al., 1994). Fromthis information, the cumulativenumber
ofmonthswith depressive symptomswas calculated and transformed into a percentage of
timewith depressive symptoms in the prior 4 years before baseline. Information on age at
onset of ﬁrst full syndrome as determined with the CIDI interview (b21 yrs vs. ≥21 yrs)
and single versus recurrent episodes (more than 1 episode during lifetime) was derived
from the CIDI. Subtype of MDD was based on a classiﬁcation of depressive subtypes
derived froma latent class analysis (LCA) amongNESDA respondents (Lamers et al., 2010).
In this LCA study, we identiﬁed three different symptom proﬁles that were labeled as a
melancholic severe subtype, an atypical severe subtype, and a moderate severe subtype,
based on symptom probabilities. Comorbid anxiety disorders were deﬁned by the CIDI as
presence of DSM-IV classiﬁed panic disorder, agoraphobia, social phobia or generalized
anxiety disorder in the pastmonth. Also the pastmonth presence of a DSM-IV diagnosis of
alcohol dependence was derived from the CIDI. Finally, current severity of depressive
symptoms was assessed at baseline with the IDS (Rush et al., 1996; Trivedi et al., 2004).
2.4. Statistical analyses
All analyses were performed using SPSS, version 17, and for all analyses two-tailed
tests were used with α=0.05. To evaluate the associations of variables with depressive
symptoms, linear regressions were performed with 1-year IDS as the dependent variable
and baseline IDS score as the covariate. First a model with risk factors was run to evaluate
thepredicting value on 1-year depressive symptoms irrespective of clinical characteristics.
Likewise, a second model only included clinical characteristics. Finally, risk factors and
clinical characteristics that had a pb0.10 in previousmodels were joined in a third model
to evaluate the independent prognostic effect of these variables on the change in
depressive symptoms. We used the cut-off of pb0.10 to minimize the chance of missing
any relevant variables in multivariable analyses. Multicollinearity of variables in the
modelswas checkedbyevaluating theVIFs, andnomulticollinearity problemswere found.
A similar stepwise approachwas used in themultinomial logistic regressionmodels, with
the categorized depression status at 1 year as outcome.
Because missing data result in loss of power and often introduce bias because of
selective response, multiple imputation (MI) was performed. Multiple imputation is a
technique in which for each missing value a set ofmN1 plausible values are drawn from
theirpredictivedistribution (Rubin, 1987; Schafer andOlsen, 1998). Because it canaccount
for the uncertainty of missing values, multiple imputation is considered to be a better
alternative than other imputationmethods (Sinharay et al., 2001).With the SPSSmultiple
imputation option, 10 imputed data sets were generated, using the fully conditional
speciﬁcation (FCS) method. Generally, 3 to 10 imputations are considered to obtain good
results, and will sufﬁce even with 40–50% missing information (Rubin, 1987; Sinharay et
al., 2001). Results fromthe analyses of the 10 separatedatasetswerepooled, correcting the
standard errors of the regression coefﬁcients for within-imputation variability and
between-imputation variability (Rubin, 1987). The use of imputation techniques for
missing data in longitudinal cohort studies is desirable but not yet a standard procedure in
psychiatric research, althoughmore andmore studies useMI in their analyses (Brotmanet
al., 2007; Carney et al., 2008; Brent et al., 2009). We therefore checked the consistency of
results in conservative analyses inwhich we only used data from personswith completed
1-year IDS scores.
3. Results
Table 1 shows the baseline characteristics of the sample (n=789).
Sixty-six percent of the sample were women and the mean age was
41.8 years (S.D. 12.0). The mean baseline IDS score was 36.0 (S.D.
11.2), whereas at 1-year follow-up the mean IDS score was 26.6 (S.D.
13.0). Of the initial sample, 18% had remitted (IDSb14), 19% was
severely depressed (IDSN38), and the majority (63%) had mild to
moderate symptoms at 1-year follow-up (Table 1).
Analyses of the predictive value of risk factors on 1-year severity of
depressive symptoms, controlled for baseline severity, revealed that
childhood trauma, higher neuroticism, not having a partner and older
age were signiﬁcantly associatedwith a higher IDS score, representing
higher depression severity at 1-year follow-up (Table 2, model 1). Of
the clinical characteristics, longer duration at baseline and comorbid
anxiety disorderswere signiﬁcantly associatedwith a higher IDS score
Table 1
Baseline characteristics of study sample (N=789).
Risk factors
Family history depression (%) 79.2
Childhood trauma, mean (S.D.) 2.3 (2.4)
Number of negative life events in past year, median (IQR) 0 (1)
Neuroticism, mean (S.D.) 43.2 (6.5)
Number of chronic diseases, median (IQR) 0 (1)
Education (yrs), mean (S.D.) 11.3 (3.2)
Having no partner (%) 36.9
Female gender(%) 66.2
Age, mean (S.D.) 41.8 (12.0)
North European ancestry (%) 92.8
Baseline clinical characteristics
Duration at baseline(percentage of 4 yrs), median (IQR) 33.9 (45.1)
Late onset (≥21yr) (%) 61.6
Recurrent MDD (%) 50.8
Depressive subtype (%) Melancholic 48.5
Atypical 26.1
Moderate 25.4
Comorbid alcohol dependence (1 mo) (%) 6.0
Comorbid anxiety disorders (1 mo) (%) 62.7
Clinical setting (%) Community 7.0
Primary care 37.8
Specialized mental health 55.3
TCA use (%) 3.7
SSRI use (%) 30.2
Other antidepressant use (%) 10.7
Psychotherapy (%) 47.1
Depressive symptoms measures
Baseline IDS score, mean (S.D.) 36.0 (11.2)
1-yr FU IDS score, mean (S.D.) 26.6 (13.0)
1-yr FU status (%): Remitted 18.3
Mild-moderate symptoms 62.5
Severe symptoms 19.2
Table 2
Pooled regression coefﬁcients for IDS at 1-year follow-up (n=789).
Model 1 Model 2 Model 3
β (se) P β (se) P β (se) P
Risk factors
Family history depression −0.836
(1.006)
0.41
Childhood trauma 0.395
(0.179)
0.03 0.321
(0.174)
0.07
Number of life events
(past yr)
−0.128
(0.374)
0.73
Neuroticism 0.279
(0.082)
b0.001 0.231
(0.085)
b0.01
Number of chronic
diseases
0.718
(0.428)
0.094 0.707
(0.422)
0.09
Education (yrs) −0.256
(0.152)
0.096 −0.184
(0.151)
0.23
Not having a partner 2.396
(1.004)
0.02 2.095
(1.015)
0.04
Female gender −0.285
(0.978)
0.77
Age 0.107
(0.037)
b0.01 0.106
(0.037)
b0.01
North European ancestry −1.771
(2.082)
0.40
Baseline clinical characteristics
Duration at baseline
(per% increase)
0.038
(0.016)
0.02 0.026
(0.016)
0.11
Late onset (N21 yr) 0.552
(0.958)
0.57
Recurrent MDD −1.820
(0.878)
0.04 −2.095
(0.867)
0.02
Depressive
subtype
Melancholic Ref
Atypical −0.762
(1.000)
0.45
Moderate −0.653
(1.269)
0.61
Clinical
setting
Primary
care
Ref
Specialized
mental
health
−0.698
(1.000)
0.49
Community −0.559
(1.699)
0.74
Comorbid alcohol
dependence
3.084
(1.869)
0.10
Comorbid anxiety
disorders
2.538
(0.973)
0.01 1.937
(1.018)
0.06
TCA use −1.466
(2.298)
0.52
SSRI use −0.003
(1.052)
0.99
Other antidepressant use 1.879
(1.443)
0.19
Psychotherapy 0.301
(0.876)
0.73
Baseline severity
IDS score
(per point increase)
0.523
(0.045)
b0.001 0.576
(0.046)
b0.001 0.491
(0.044)
b0.001
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2). Notably, setting and treatment variables were not associated with
IDS score at 1-year follow-up. In the third model, including all
variables with a p-valueb0.10 in previous models, most variables
remained signiﬁcant predictors of a higher depression severity, with
the exception of childhood trauma, duration of depression at baseline
and comorbid anxiety, although comorbid anxiety was marginally
associated with a higher IDS score in this model. The estimate of
childhood trauma decreased with 18%, indicating mediation by
clinical characteristics. Baseline depressive symptom severity was a
strong predictor of one-year depressive severity in all models. The
explained variance (R square) of the models in the 10 imputed
datasets ranged from 0.34 to 0.38 for model 1 and 2, and from 0.37 to
0.40 for model 3.
Along with the continuous outcome measure, we evaluated a
categorical variable in which we compared a group of persons with
mild-moderate depression after 1 year with those who had remitted
(IDSb14) and those who had severe depression (IDSN38). Of the risk
factors, only younger age was signiﬁcantly associated with remission
and this association was marginally signiﬁcant (p=0.09) in the full
model (model 3, Table 3). Of the clinical characteristics the absence of
comorbid anxiety disorder, moderate subtype of depression (compared
to the melancholic subtype) and a lower baseline severity were
associated with a higher relative risk of remission. Higher neuroticism
and higher baseline severity were signiﬁcantly associatedwith a higher
relative risk of being severely depressed at 1-year. The explained
variance (Nagelkerke) of the models in the 10 imputed datasets ranged
from 0.33 to 0.37 for model 1, 0.35 to 0.37 for model 2 and 0.35 to 0.38
for model 3.
Multiple imputation was performed because approximately 25% of
the sample had missing IDS data at 1-year follow-up due to non-
response. Applying the step-wise analytical approach in the original,
non-imputed dataset led to the inclusion of recurrent depression to thelogistic regression model. Also, in the original data, number of chronic
diseases was not included in model 3 of the logistic regression, but
otherwise all other outcomes were highly comparable (data not
shown).4. Discussion
This study evaluated the associations of both risk factors and clinical
characteristics on the severity of depressive symptoms at 1-year follow-
up in a cohort of patients withMDD. Our study showed that several risk
factorswere predictive of a poorer outcome after 1 year, independent of
baseline clinical characteristics. High neuroticism was a predictor of
Table 3
Pooled relative risks (95% conﬁdence intervals) for remission after 1 year, and for presence of severe symptoms after 1 year (reference group are those with mild-moderate
symptoms after 1 year) (n=789).
Remitted after 1 year (IDSb14) Severe symptoms after 1 year (IDSN38)
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Risk factors
Family history depression 0.96 (0.54–1.71) 0.76 (0.44–1.32)
Childhood trauma 0.96 (0.87–1.06) 1.05 (0.95–1.15)
Number of life events (past yr) 0.96 (0.78–1.18) 1.00 (0.79–1.27)
Neuroticism 0.98 (0.96–1.02) 0.98 (0.94–1.03) 1.07 (1.02–1.12)‡ 1.06 (1.01–1.12)†
Number of chronic diseases 0.77 (0.57–1.04)⁎ 0.79 (0.58–1.08) 1.11 (0.89–1.38) 1.15 (0.93–1.43)
Education (yrs) 1.08 (0.99–1.17)⁎ 1.07 (0.99–1.17) 1.00 (0.93–1.08) 1.00 (0.93–1.08)
Not having a partner 0.63 (0.38–1.07)⁎ 0.63 (0.37–1.07)⁎ 1.36 (0.86–2.14) 1.41 (0.89–2.21)
Female gender 0.85 (0.51–1.44) 0.88 (0.54–1.44)
Age 0.98 (0.96–0.99)† 0.98 (0.96–1.00)⁎ 1.01 (0.99–1.03) 1.01 (0.99–1.04)
North European ancestry 1.44 (0.45–4.62) 0.74 (0.31–1.79)
Baseline clinical characteristics
Duration at baseline (per% increase) 0.99 (0.98–1.01) 1.01 (0.99–1.01)
Late onset (N21 yr) 0.91 (0.56–1.47) 1.27 (0.78–2.07)
Recurrent MDD 1.34 (0.81–2.24) 0.68 (0.42–1.12)
Depressive subtype Melancholic Ref Ref Ref Ref
Atypical 1.38 (0.74–2.59) 1.23 (0.65–2.34) 1.14 (0.68–1.89) 1.12 (0.67–1.89)
Moderate 1.82 (0.99–3.33)⁎ 1.94 (1.06–3.57)† 1.61 (0.63–4.13) 1.56 (0.61–4.00)
Setting Primary care ref ref ref ref
Specialized mental health 2.09 (1.19–3.64)† 1.69 (0.97–2.93)⁎ 1.33 (0.79–2.24) 1.44 (0.86–2.41)
Community 1.43 (0.60–3.44) 1.41 (0.61–3.26) 0.81 (0.26–2.49) 0.75 (0.24–2.37)
Comorbid alcohol dependence 0.84 (0.30–2.38) 1.74 (0.69–4.42)
Comorbid anxiety disorder 0.55 (0.35–0.89)† 0.57 (0.35–0.95)† 1.31 (0.73–2.33) 1.32 (0.73–2.38)
TCA 0.92 (0.22–3.84) 0.79 (0.26–2.45)
SSRI 0.67 (0.37–1.19) 0.95 (0.55–1.63)
Other Antidepressants 0.62 (0.24–1.56) 1.48 (0.69–3.20)
Psychotherapy 0.98 (0.60–1.60) 0.95 (0.59–1.55)
Baseline severity
IDS score (per point increase) 0.93 (0.90–0.96)‡ 0.94 (0.91–0.97)‡ 0.94 (0.91–0.97)‡ 1.10 (1.07–1.13)‡ 1.12 (1.09–1.15)‡ 1.10 (1.07–1.14)‡
‡ pb0.01.
† pb0.05.
⁎ pb0.10.
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were predictors of poorer outcome in linear regression analyses, and
were marginally associated with remission in the logistic regression. Of
the clinical characteristics, higher baseline severity predicted poorer
outcome. Having a ﬁrst episode (versus a recurrent episode) was also
associated with poorer outcome, but only in linear regression analyses.
Comorbid anxiety lowered the chance of remission, while having a
moderate subtype (compared to the melancholic subtype) increased
the chance of remission.
One of the reasons for performing these analyses is that, although
risk factors have often been found to predict course of MDD, these
were often not studied in concert with other predictors of course like
clinical characteristics, leaving question marks about which risk
factors are associated with course independent of clinical character-
istics. The NESDA study – with its extensive data collection – allowed
for the evaluation of a large set of risk factors and clinical
characteristics within a large sample of persons with MDD. We
found that the effects of not having a partner, older age and higher
neuroticism were independent of clinical characteristics. Our study
showed that high neuroticism was associated with poorer outcome at
1-year follow-up even when clinical characteristics were taken into
account, implying that neuroticism has a unique inﬂuence on
outcome of MDD. Most other studies found similar ﬁndings, but
rarely included potential predictive clinical characteristics in their
models (Mulder, 2002). Several studies have shown that not having a
partner predicted poor outcome in univariable but not in multivar-
iable analyses (O'Leary et al., 2000; Trivedi et al., 2006).We found that
not having a partner was an independent determinant for more
depressive symptomatology after 1 year, and was marginally associ-
ated with a lower chance of remission. With respect to age, previous
studies found mixed results. In contrast to ﬁndings of Spijker andcolleagues who found younger age to be associated with poor
outcome after 1 year (Spijker et al., 2001), we found younger age to
be marginally associated with remission and older age to be
associated with higher levels of depressive symptoms after 1 year.
We further observed that the effect of childhood trauma on
depression severity weakened and was no longer signiﬁcant when
analyzed simultaneously with clinical characteristics. As previous
research showed that childhood trauma is associated with a longer
duration of MDD(Wiersma et al., 2009), which itself was a signiﬁcant
predictor of poorer outcome, the weakened effect of childhood
trauma is not surprising. Also, the effect of the number of chronic
diseases on the relative risk of having severe symptoms was no longer
signiﬁcant when clinical characteristics were taken into account.
However, this is in contrast with ﬁndings from other studies showing
that having more physical diseases was associated with poorer course
in multivariable analyses including depression severity (Spijker et al.,
2004; Trivedi et al., 2006).
Of the clinical characteristics, comorbid anxiety disorder is a well-
known determinant of unfavorable course of MDD (Bagby et al., 2002;
Kaptein et al., 2007). In the current study we found that for persons
with comorbid anxiety disorder the chance of remission was 43%
lower than in persons without comorbid anxiety. In contrast with
previous studies (Klein et al., 2006; Rhebergen et al., 2008), we found
that longer duration of MDD at baseline did not predict higher IDS
scores at follow-up after inclusion of risk factors to the model. The
ﬁnding that a higher depression severity at baseline was associated
with a higher relative risk on poor course and a lower relative risk on
remission is also in accordance with previous studies (Keller et al.,
1992; Melartin et al., 2004; Iacoviello et al., 2006; Trivedi et al., 2006;
Blom et al., 2007; Iacoviello et al., 2007; Conradi et al., 2008). While
studies have reported that recurrent episodes are generally more
230 F. Lamers et al. / Psychiatry Research 190 (2011) 226–231severe and indicative of a worse longitudinal course (Bagby et al.,
2002; Hollon et al., 2006; Roca et al., 2011), in the NESDA, however,
having a ﬁrst episode predicted a worse course, although only in
linear regression analysis. This ﬁnding may be partially explained by
the fact that symptom severity – which is increasing with number of
episodes (Roca et al., 2011), and a predictor of poor outcome – was
also included in the model. Further, in the NESDA a relatively large
number of persons had a ﬁrst episode with a long duration, and in fact
the percentage of time with depressive symptoms in the 4 years prior
to baseline was signiﬁcantly higher in persons with a ﬁrst episode
compared to persons with recurrent episodes. Persons with a ﬁrst
episode may thus be just as affected as persons with recurrent
episodes, and this may explain our ﬁnding that persons with a ﬁrst
episode had a poorer outcome. Surprisingly, none of the treatment
variables (tricyclic antidepressants, selective serotonin reuptake
inhibitors, other antidepressants or psychotherapy) was associated
with outcome, nor was recruitment setting in the ﬁnal models. An
additional analysis with a combined variable for any type of treatment
(yes/no) also showed no association with symptoms after 1 year.
Several limitations of this study need to be noted. We studied
relatively short-term outcome of severity (1-year follow-up), mean-
ing that the identiﬁed predictors are not per se also predictors of long-
term severity of depressive symptoms. The assessment of severity of
depression at 1-year follow-up does not further inform us about the
ﬂuctuations of severity during the year, that are likely to have
occurred (Judd, 1997). Thus, we do not know for how long theMDD in
the remitted group had been absent, leaving unclear how many of
these persons were indeed in remission according to the frequently
used deﬁnition of no signiﬁcant signs or symptoms for at least 2–4
consecutive weeks (Keller, 2003; Rush et al., 2006). Likewise, we
cannot distinguish between those who were chronically depressed
versus those who had been in remission during some time of the
follow-up and subsequently developed relapse or recurrence prior to
the assessment at 1-year follow-up. Finally, because 25% of the sample
had missing data, and non-responders tended to be younger, less
educated, less often of North-European descent and less often had
recurrent depression, analyzing only persons with complete follow-
up data would lead to biased outcomes. Multiple imputation (MI) was
therefore performed to impute missing data in an effort to overcome
such bias. Generally, within MI, 3 to 10 imputations are considered to
obtain good results, even with 40–50% missing information (Rubin,
1987; Sinharay et al., 2001). As mentioned in the results, analyses of
persons with complete data showed highly comparable results.
This study showed that only a limited number of risk factors and
clinical characteristics were predictive of 1-year severity of depressive
symptoms in persons with MDD. Along with those with more severe
MDD, comorbid anxiety ﬁrst episode or moderate subtype, persons
who are older, persons without a partner, and persons with high
neuroticism may experience more severe depressive symptoms and
may require closer monitoring in daily practice. Assessment of these
risk factors in patients with MDD may aid clinicians in predicting a
patient's prognosis and may aid decisions on the intensity and
duration of treatment. The risk factor childhood trauma on the other
hand appeared to be largely mediated through more unfavorable
clinical characteristics at baseline.
To conclude, within a large cohort of MDD patients both risk factors
and clinical characteristics independently predicted 1-year severity of
depressive symptoms. This implies that the prediction of prognosis and
the identiﬁcationof persons at risk of a poor outcomeshould not only be
based on clinical characteristics, but on risk factors as well.Acknowledgment
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